🔎 Trials Near Me

Home › Ovarian Epithelial Carcinoma › Minnesota › Minneapolis

Ovarian Epithelial Carcinoma clinical trials in Minneapolis, MN

5 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

RecruitingPhase 2
  • University of Minnesota - Minneapolis /ID# 275718, Minneapolis
  • Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 274780, Saint Louis Park · 5 mi away
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

RecruitingPhase 3
  • Research Site, Minneapolis
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT07218809

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

RecruitingPhase 3
  • Minnesota Oncology Hematology PA, Minneapolis
Ages 18 and older · Women · Updated Jul 2, 2026 · NCT06819007

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

RecruitingPhase 2
  • SCRI - Minnesota Oncology Hematology, P.A., Minneapolis
  • University of Minnesota, Minneapolis
Ages 18 and older · Women · Updated Dec 23, 2025 · NCT06690775

Ovarian Epithelial Carcinoma trials in other cities

Other studies in Minneapolis

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.